Dyne Therapeutics, Inc. - COMMON STOCK (DYN)

CUSIP: 26818M108

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / COMMON STOCK
Shares outstanding
164,064,426
Total 13F shares
110,972,098
Share change
+15,560,726
Total reported value
$3,915,861,443
Put/Call ratio
30%
Price per share
$35.29
Number of holders
191
Value change
+$555,159,053
Number of buys
122
Number of sells
66

Quarterly Holders Quick Answers

What is CUSIP 26818M108?
CUSIP 26818M108 identifies DYN - Dyne Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Dyne Therapeutics, Inc. - COMMON STOCK (DYN) as of Q2 2024

As of 30 Jun 2024, Dyne Therapeutics, Inc. - COMMON STOCK (DYN) was held by 191 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 110,972,098 shares. The largest 10 holders included Atlas Venture Life Science Advisors, LLC, FCPM III SERVICES B.V., BlackRock Inc., RTW INVESTMENTS, LP, RA CAPITAL MANAGEMENT, L.P., FMR LLC, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, CITADEL ADVISORS LLC, and Deep Track Capital, LP. This page lists 191 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.